Interruption of ghrelin signaling in the PVN increases high-fat diet intake and body weight in stressed and non-stressed C57BL6J male mice by Zachary R. Patterson et al.
ORIGINAL RESEARCH ARTICLE
published: 17           September 2013
doi: 10.3389/fnins.2013.00167
Interruption of ghrelin signaling in the PVN increases
high-fat diet intake and body weight in stressed and
non-stressed C57BL6J male mice
Zachary R. Patterson*, Tamara Parno , Albert M. Isaacs and Alfonso Abizaid
Department of Neuroscience, Carleton University, Ottawa, ON, Canada
Edited by:
Zane B. Andrews, Monash
University, Australia
Reviewed by:
Víctor M. Navarro, Brigham and
Women’s Hospital/Harvard Medical
School, USA
Zane B. Andrews, Monash
University, Australia
*Correspondence:
Zachary R. Patterson, Department of
Neuroscience, Carleton University,
Life Science Research Building,
1125 Colonel By Dr., Ottawa, ON,
K1S 5B6, Canada
e-mail: zack.patterson@gmail.com
Chronic social stress has been associated with increased caloric intake and adiposity.
These effects have been linked to stress induced changes in the secretion of ghrelin,
a hormone that targets a number of brain regions to increase food intake and energy
expenditure and promote increased body fat content. One of the brain sites targeted by
ghrelin is the hypothalamic paraventricular nucleus (PVN), a region critical for both the
regulation of the stress response and the regulation of energy balance. Given these
data, we examined the contribution of ghrelin receptors in the PVN to the metabolic
and behavioral changes that are seen during chronic social stress in mice. To do this,
mice were implanted with cannulae attached to osmotic minipumps and delivering
either vehicle or the ghrelin receptor (growth hormone secretagogue receptor) antagonist
[D-Lys-3]-GHRP-6 (20 nmol/day/mouse). Following a week of recovery, half of the animals
in each group were exposed to chronic social defeat stress for a period of 3 weeks
whereas the other half were left undisturbed. During this time, all animals were given
ad libitum access to standard laboratory chow and presented a high-fat diet for 4 h during
the day. Results showed that the ghrelin receptor antagonism did not decrease stressed
induced caloric intake, but paradoxically increased the intake of the high fat diet. This
would suggest that ghrelin acts on the PVN to promote the intake of carbohydrate rich
diets while decreasing fat intake and blockade of ghrelin receptors in the PVN leads to
more consumption of foods that are high in fat.
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INTRODUCTION
In mammals, environmental stressors result in the activation
of a number of homeostatic and allostatic physiological mech-
anisms that enable the organism to deal with the impending
threat (McEwen, 2007). One of these mechanisms involves the
activation of the hypothalamic pituitary adrenal (HPA) axis,
a major neuroendocrine system that controls the response to
stress. Thus, in the face of a stressor, parvocellular cells in the
paraventricular nucleus (PVN) of the hypothalamus secrete corti-
cotropin releasing hormone (CRH) onto the portal system in the
median eminence and onto the anterior pituitary. Here CRH acts
on corticotropes to elicit the secretion of adrenal corticotropin
releasing hormone (ACTH) into the blood stream (Smith and
Vale, 2006). Increased circulating levels of ACTH stimulate cells
in the adrenal cortex to release glucocorticoids (Stratakis and
Chrousos, 1995; Smith and Vale, 2006). Increased levels of glu-
cocorticoids are important for a number of reasons that include
the release of glucose and glycogen stores from the liver and
muscle, and the release of insulin from the pancreas facilitat-
ing the generation of energy required to meet the energetic
demands posed by the stressor (Black, 2006). Glucocorticoids
then provide a negative feedback signal to the hypothalamus and
hippocampus to terminate any further activation of the HPA axis
(McEwen, 2007).
Recently, the orexigenic hormone ghrelin has emerged as
another hormone that is secreted in response to stressors and
one that may produce some of the metabolic changes required
to deal with the energetic demands posed by the stressors
(Patterson et al., 2013). In addition to increasing food intake
and growth hormone secretion, ghrelin promotes the utiliza-
tion of carbohydrates as a fuel source, while preventing the
use of lipids, resulting in increases in body weight due to
increases in body fat (Kojima et al., 1999; Tschop et al., 2000).
Moreover, these effects are produced by ghrelin acting centrally
(Tschop et al., 2000; Nakazato et al., 2001; Patterson et al.,
2013). Under normal conditions, ghrelin is secreted in circa-
dian patterns, or in anticipation of scheduled meals (Cummings
et al., 2001; Drazen et al., 2006). Nevertheless, ghrelin is also
secreted in response to acute stressors, and circulating ghrelin
levels are higher in chronically stressed animals (Lutter et al.,
2008; Patterson et al., 2009, 2013). Thus, animals that are
exposed to repeated social stressors often show increased caloric
intake, body weight, and adiposity in tandem with increased
ghrelin concentrations (Lutter et al., 2008; Bartolomucci et al.,
2009; Kumar et al., 2013; Patterson et al., 2013). More impor-
tantly, ghrelin mediates these effects through its action on
brain sites that contain the GHSR (Patterson et al., 2013).
These data support the notion that stress generates a metabolic
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challenge, and that ghrelin is released as part of the physio-
logical mechanisms that are generated to meet this challenge.
Interestingly, mice with mutations to the only known ghrelin
receptor, the growth hormone secretagogue receptor (GHSR),
are more susceptible to develop depressive like behaviors after
chronic social stress compared to their wild type (WT) littermates
(Lutter et al., 2008).
While it is clear that stress-induced ghrelin secretion affects
food intake and energy balance through central actions (Patterson
et al., 2013), not much is known about the relative contribution
of different ghrelin-sensitive brain regions, many of which are
implicated in the behavioral and metabolic responses to stress.
Among these regions, the PVN stands out given its role in the
regulation of the HPA axis as well as in the modulation of sympa-
thetic responses, and its connections with peripheral tissues such
as the liver, pancreas and adipose tissues (Hill, 2013). Ghrelin
receptors are found within the PVN although it appears that they
do not co-localize with CRH producing neurons (Guan et al.,
1997; Zigman et al., 2006; Cabral et al., 2012). Nevertheless,
ghrelin acting on other cells in the PVN could be responsi-
ble for some of the behavioral and metabolic alterations that
are produced by exposure to chronic social stress (Cabral et al.,
2012). To examine this possibility, we exposed mice to chronic
social defeat stress for a period of 21 days while being infused
with a ghrelin receptor antagonist ([D-Lys-3]-GHRP-6) or vehi-
cle (0.9% saline) and compared their metabolic phenotypes
with non-stressed controls receiving the same drug or vehicle
infusions.
MATERIALS AND METHODS
ANIMALS
Male C57BL6Jmice weighing 20–22 g were obtained fromCharles
River farms, St. Constant, Quebec as experimental subjects.
Mice (N = 48) were housed under standard laboratory condi-
tions with ad libitum access to mouse chow (3.3 kcal/g, with
70% of calories derived from carbohydrates) and tap water in
addition to daily 4-h high fat diet containing 60% caloric con-
tent from fat (TD 06414, Harlan). The calculated metabolized
energy of the high fat diet was 5.1 kcal/g with 60.0% calories
from fat. Male CD-1 retired breeder mice weighing 40–50 g, also
obtained from Charles River Farms, were used as aggressors in
the chronic social defeat stress paradigm. Food intake (both stan-
dard laboratory chow and high-fat diet) and body weight were
weighed and recorded daily by the experimenters at 9:00 AM.
The high-fat diet was available from 10:00 AM to 2:00 PM daily.
Following the baseline period, mice were separated into 4 exper-
imental groups as follows: vehicle stressed (n = 12), vehicle non-
stressed (n = 12), [D-Lys-3]-GHRP-6 non-stressed (n = 12) and
[D-Lys-3]-GHRP-6 stressed (n = 12). Due to attrition of ani-
mals throughout the 28-day cannula-minipump infusion pro-
cess, as well as misplaced cannulae, the final group numbers
used for data analysis were as follows: vehicle stressed (n = 6),
vehicle non-stressed (n = 10), [D-Lys-3]-GHRP-6 non-stressed
(n = 4) and [D-Lys-3]-GHRP-6 stressed (n = 6). All procedures
documented were approved by the Carleton University Animal
Care Committee and the guidelines of the Canadian Council on
Animal Care were followed.
STEREOTAXIC SURGERY—CHRONIC DELIVERY OF GHRELIN RECEPTOR
ANTAGONIST INTO THE PARAVENTRICULAR NUCLEUS OF THE
HYPOTHALAMUS
Prior to surgery, we conducted a 2-week baseline where mea-
sures of food intake (both standard laboratory chow and high
fat diet) and body weight were recorded daily. After baseline,
mice were anesthetized using isofluorane mixed with oxygen
(4%) and implanted with an intracranial cannula connected to an
osmotic minipump delivering either saline or the ghrelin recep-
tor antagonist [D-Lys-3]-GHRP-6. To do this, the mouse’s head
was shaved and secured onto a mouse stereotaxic apparatus while
anaesthetized (Kopf Instruments, Tujunga, CA). The scalp was
cleaned with surgiprep and privodine to provide an aseptic can-
vas. Tear gel was applied to prevent dehydration of the eyes.
A midline incision was made and the skin was retracted for a
clear visualization of bregma. A 28 gauge stainless steel unilat-
eral cannula (Alzet Brain Infusion Kit; Order #004760) coupled
to an osmotic mini-pump (Alzet Mini-Osmotic Pump—Model
1004; flow rate: 0.11μL/h for 28 days) using a polyethylene
catheter and was implanted into the PVN of the hypothalamus.
Stereotactic coordinates of the cannula, relative to bregma, were
AP −0.94mm, ML −1.75mm and DV 4.83mm (Paxinos and
Franklin, 1997). Mini-pumps were filled with 100μL of sterile
saline (0.9% NaCl) to the control group while the experimental
group had mini-pumps filled with 100μL of the ghrelin receptor
antagonist ([D-Lys-3]-GHRP-6) solution (Peptides International;
20 nmol/day/mouse). The implant was secured with contact and
dental cement. When the cement was dry, the dorsal portion of
the skin was separated from the muscle using blunt dissection to
implant the mini-pump subcutaneously. The incision was closed
using silk surgical sutures. Polysporin and Lidocaine were applied
topically to the surgical site to prevent bacterial infection and
pain, respectively. Mice were also injected with a low dose of
meloxicam (Metacam, 0.1mL of 5mg/mL) to provide postopera-
tive analgesia. Following surgery, mice were moved to a recovery
area in a clean cage with a heating pad. Upon wakening, mice
were monitored closely for optimal recovery for a total of 7 days
following surgery.
CHRONIC SOCIAL DEFEAT STRESS PARADIGM
Following the 1 week recovery period after surgery, half of the
saline and half of the ghrelin receptor antagonist infused mice
were taken from their room and transported to another room
where each of them was housed in a cage inhabited by a much
larger sexually experience male CD-1 mouse for the next 21 days
(Patterson et al., 2013). The experimental mice were protected
from the aggressive CD-1 mice by an acrylic divider and wire
mesh, yet olfactory, visual, and auditory contact was maintained
with the resident for the entire 21-day stress period. Each day, the
divider was removed and the animals were permitted to interact
until the experimental mouse was subdued or until 15min had
passed. Measurements of regular chow intake, high fat diet intake,
and body weight were recorded each day during the stress period.
BLOOD PLASMA COLLECTION
At the end of the 21 days of chronic social defeat stress, mice
in the stress group were sacrificed by rapid decapitation, the
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morning following the last social interaction with the domi-
nant mouse. Non-stressed mice were sacrificed on the same day.
Glucose concentrations from trunk blood samples were recorded
using Accuchek® (Aviva) glucose meter and strips. Blood samples
were also collected for analyses of plasma corticosterone (CORT)
content. These samples were analyzed using a radioimmunoassay
kit according to the manufacturer’s protocol (ICN Biomedicals,
CA, USA). Inter assay variability was less than 10%.
STATISTICS
All data were analyzed using 2 × 2 ANOVAs with drug
([D-Lys-3]-GHRP-6 vs. 0.9% saline) and treatment (stress vs.
non-stress) as the between group factors, unless otherwise stated.
Data from animals with misplaced cannula were not included in
the analyses. All analyses were preceded with a Levene’s Test of
Quality of Error Variance to ensure the homogeneity of variance
assumption was satisfied. The limit for statistical significance was
set at α = 0.05. All mice with misplaced cannula were eliminated
from all statistical analysis.
RESULTS
HISTOLOGY
Postmortem analyses of cannulae placements showed that six
mice had misplaced cannulae (Vehicle non-stressed miss, n = 1;
Vehicle stressed miss, n = 1; [D-Lys-3]-GHRP-6 non-stressed
miss, n = 2; [D-Lys-3]-GHRP-6 stressed miss, n = 2). The loca-
tion of the cannulae for animals in each group is shown in
Figure 1. As seen in this figure, most placements were located in
the dorsolateral portion of the PVN. Because the cannulae were
inserted on an angle (18◦), most missed cannulae were placed too
far lateral to the PVN, with only a few placed too far dorsal. The
data from these animals were not included in the analyses given
that there were only one or two animals from each group that
had misplaced cannulae. Nevertheless, none of the animals with
misplaced cannulae and receiving [D-Lys-3]-GHRP-6 showed the
effects observed below suggesting that these effects were caused by
localized action of the drug onto the PVN and not at sites outside
of this region.
FIGURE 1 | Location of cannulae placement in animals from each
group. Animals with missed cannulae placements were not included in this
figure or in the analyses.
STRESS INCREASES CALORIC INTAKE IN MICE AND THIS EFFECT IS
NOT ATTENUATED BY GHSR ANTAGONISM IN THE PVN
Total caloric intake was calculated daily throughout the study
by adding the caloric content of standard laboratory chow and
high-fat diet. At the end of the baseline period, mice were
assigned to each of the experimental groups after being matched
for total caloric intake. As such, there were no group differ-
ences in the amount of calories consumed during the baseline
(data not shown). During the week that followed the surgi-
cal implantation of the cannulae, mice continued to eat similar
amounts of calories and there were no differences between any
of the groups. During the stress period, there was no significant
interaction between drug and treatment on caloric consumption
[interaction, F(1, 22) = 0.019, p > 0.05], nor was there an effect
of [D-Lys-3] GHRP-6 treatment [main effect of drug, F(1, 22) =
3.099, p > 0.05]. There was, however, a significant treatment
effect where stressedmice increased their total daily caloric intake,
and this effect was not attenuated by GHSR antagonism [main
effect of stress, F(1, 22) = 11.77, p < 0.05; See Figure 2A].
The increase in caloric intake seen in stressed animals was due
primarily to an increase in the daily intake of regular chow. Both
vehicle and [D-Lys-3] GHRP-6 treated mice consumed equiva-
lent amounts of chow before the stress period began (p > 0.05).
Following the stress period, there was no significant interac-
tion between drug and treatment on the consumption of regular
chow [interaction, F(1, 22) = 0.063, p > 0.05]. However, we did
observe a significant treatment effect, where stressed mice rapidly
increased their intake of regular laboratory chow regardless of the
infusion they received in the PVN [main effect of stress, F(1, 22) =
10.48, p < 0.05; See Figure 2B].
FIGURE 2 | (A) Average daily caloric intake (calculated as the sum of
calories consumed from standard laboratory chow and high-fat diet), (B)
average daily standard laboratory chow intake, (C) average number of
calories consumed from the high fat diet per day for animals receiving
either vehicle (0.9% saline) or 20 nmol/day of [D-Lys3-]-GHRP-6; stressed
and non-stressed animals are collapse to illustrate main effect of drug. All
values are expressed as mean ± s.e.m. ∗p < 0.05 relative to non-stressed
controls. ψp = 0.05 relative to vehicle treated animals.
www.frontiersin.org September 2013 | Volume 7 | Article 167 | 3
Patterson et al. Ghrelin signalling in the PVN
BLOCKING GHSR IN THE PVN INCREASES THE INTAKE OF THE HIGH
FAT DIET
Given that stress has been associated with increased consumption
of diets that are calorically dense and highly palatable, we next
examined if chronic social defeat stress would alter the intake of
a high-fat diet. Mice in all groups ate little of the high fat diet
early in the baseline period but increased their intake steadily over
time, so that by the end of the baseline period, they were con-
suming about 37% ± 4.7 of their daily caloric intake from this
diet. There was no significant interaction between treatment and
drug on the proportion of calories obtained from the high-fat diet
during the stress period [interaction, F(1, 22) = 0.411, p > 0.05].
However, there was a significant treatment effect wherein the pro-
portion of calories obtained from the high fat diet decreased in all
animals that were stressed [main effect of stress, F(1, 22) = 4.32,
p < 0.05; data not shown]. Interestingly, there was also an effect
of drug wherein mice receiving [D-Lys-3] GHRP-6 infusions
into the PVN increased the total amount of high fat diet con-
sumed, relative to animals receiving vehicle infusions regardless of
their treatment conditions [main effect for drug, F(1, 22) = 4.25,
p = 0.051; See Figure 2C].
The increase in the total amount of fat consumed by animals
infused with [D-Lys-3] GHRP-6 into the PVN was reflected in
their body weight at the end of the stress period. There was no
significant interaction between drug and treatment on the change
in body weight during the stress period [interaction, F(1, 22) =
0.00, p > 0.05] or on the average body weight at the end of the
stress period [interaction, F(1, 22) = 0.425, p > 0.05]. There was,
however, a significant effect of drug infusions on the change in
body weight, wherein mice treated chronically with [D-Lys-3]
GHRP-6 weighed significantly more at the end of the stress period
compared to animals treated with vehicle, regardless of their treat-
ment group [main effect of drug, F(1, 22) = 12.49, p < 0.05; See
Figure 3A].
The effects of [D-Lys-3]-GHRP-6 on body weight were more
pronounced when the data were expressed as a change from
baseline, and a significant drug effect demonstrates that animals
treated with [D-Lys-3]-GHRP-6 gained more weight than those
treated with saline during the stress period [main effect for drug,
F(1, 22) = 7.32, p < 0.05; See Figure 3B]. Furthermore, there was
a significant main effect of treatment on body weight gain. As
expected, stressed mice gained significantly more weight than
FIGURE 3 | (A) Body weight at the end of the 3 week chronic social defeat
paradigm, and (B) the change of body weight during the stress period. All
values are expressed as mean ± s.e.m. ∗p < 0.05 relative to animals
receiving vehicle infusions.
their non-stressed controls, however, this occurred independently
of their drug treatment [main effect of stress, F(1, 22) = 4.65,
p < 0.05; See Figure 3B].
[D-Lys-3]-GHRP6 INFUSIONS INTO THE PVN DOES NOT INFLUENCE
STRESS-INDUCED HYPERGLYCEMIA BUT DOES MEDIATE
STRESS-INDUCED CORT SECRETION
Following sacrifice by rapid decapitation, trunk blood was ana-
lyzed for blood glucose and corticosterone. There was no interac-
tion between drug and treatment on circulating blood glucose at
the time of sacrifice [interaction, F(1, 22) = 1.238, p > 0.05]. As
expected, mice exposed to chronic social defeat stress had higher
basal glucose levels at the time of sacrifice [Figure 4A; main
effect of stress, F(1, 22) = 5.6, p < 0.05], and this effect was not
altered by [D-Lys-3] GHRP-6 infusions into the PVN (p > 0.05).
Similarly, stressed mice had significantly higher levels of circu-
lating CORT at the time of sacrifice compared to non-stressed
controls, independent of drug treatment [main effect of stress,
F(1, 22) = 12.263, p < 0.01]. Furthermore, animals receiving [D-
Lys-3]-GHRP-6 infusions into the PVN tended to have higher
circulating CORT at the time of sacrifice regardless of their treat-
ment group [main effect of drug, F(1, 22) = 4.118, p = 0.058],
and this main effect appeared to come from increased plasma
CORT in samples collected from stressed [D-Lys-3]-GHRP-6
infused animals (Figure 4B). There was, however, no interaction
effect between drug and treatment on circulating plasma CORT
at the time of sacrifice [interaction, F(1, 22) = 2.788, p = 0.110].
DISCUSSION
Ghrelin is a peptide that acts centrally to increase food intake
and to alter metabolism by promoting the oxidation of carbo-
hydrates while sparing the oxidation of fatty acids as substrate,
ultimately increasing adipose tissue accumulation (Tschop et al.,
2000). The effects of ghrelin on food intake and carbohydrate
utilization have been mimicked by direct infusions of ghrelin
onto the PVN (Currie et al., 2005). Similar to chronic delivery
of ghrelin, acute and chronic social defeat stress increase the con-
centrations of the active form of ghrelin in plasma, but also result
in higher caloric intake, and in some cases increased body weight,
effects that are attenuated in socially defeated ghrelin receptor KO
mice (Lutter et al., 2008; Davies et al., 2009; Raspopow et al., 2010;
Kumar et al., 2013; Patterson et al., 2013). Interestingly, this type
FIGURE 4 | (A) Plasma blood glucose levels and (B) plasma corticosterone
levels in trunk blood collected at the time of sacrifice. All values are
expressed as mean ± s.e.m. ∗p < 0.05 relative to non-stressed animals;
ψp < 0.05 relative to vehicle treated animals.
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of social stress causes mice to alter their metabolism to promote
the utilization of carbohydrates, ultimately leading to increased
adipose stores (Davies et al., 2009; Patterson et al., 2013). In con-
trast, ghrelin receptor KO mice continue to use fat as a substrate
for nutrients and tend to lose body fat when chronically stressed,
ultimately showing depletion of adipose tissue (Patterson et al.,
2013). Furthermore, ghrelin seems to produce these metabolic
effects centrally as chronic delivery of [D-Lys-3]-GHRP-6 into the
cerebral ventricles decreases stress induced food intake and body
weight gain (Patterson et al., 2013).
In order to produce these effects, ghrelin may be targeting
a number of central sites that contain the ghrelin receptor and
that are involved in food intake and metabolic rate, as well as in
the regulation of the stress response including the hypothalamic
PVN (Guan et al., 1997; Zigman et al., 2006). The present study
was designed to examine the contribution of ghrelin receptors
in the hypothalamic PVN in modulating some of the metabolic
effects caused by chronic social defeat stress in mice. The results
from the current experiment indicate that chronic ghrelin recep-
tor blockade in the PVN via infusions of [D-Lys-3]-GHRP-6, does
not attenuate stress induced increases in caloric intake or body
weight, nor does it affect plasma levels of glucose. Interestingly,
while stress decreased the intake of a high fat diet that was pro-
vided for 4 h during the day, [D-Lys-3]-GHRP-6 treated mice
tended to consume more of this diet compared to animals receiv-
ing vehicle infusions and this effect was independent from stress.
Not surprisingly, [D-Lys-3]-GHRP-6 treated mice weighed more
than vehicle treated mice. Furthermore, these animals also tended
to have elevated levels of circulating CORT regardless of the
treatment. These effects were not observed in the few animals
that received [D-Lys-3]-GHRP-6 infusions into areas outside
the PVN (i.e., missed cannula placements) supporting the evi-
dence that GHSR signaling in the PVN selectively mediates these
effects.
Given that acute direct infusion of ghrelin into the PVN
increase food intake in rats (Currie et al., 2005) we expected that
stress induced increases in caloric intake would be attenuated
by chronic blockade of ghrelin receptors using [D-Lys-3]-GHRP-
6. Nevertheless, [D-Lys-3]-GHRP-6 was ineffective in decreasing
caloric intake. In contrast, work from our lab has demonstrated
that [D-Lys-3]-GHRP-6 delivered into the ventricles while ani-
mals are being stressed does decrease stress induced caloric intake
(Patterson et al., 2013). It is therefore likely that, when infused
into the ventricles, [D-Lys-3]-GHRP-6 blocks the ghrelin receptor
in regions of the brain other than the PVN to reduce feed-
ing including the ventromedial hypothalamus (VMH), arcuate
nucleus (ARC), ventral tegmental area (VTA) and brain stem
nuclei like the parabrachial nucleus and nucleus of the solitary
tract (NTS), all implicated in the feeding responses to ghrelin
(Tschop et al., 2000; Nakazato et al., 2001; Faulconbridge et al.,
2003; Naleid et al., 2005; Abizaid et al., 2006; Skibicka et al., 2011).
In this sense, central blockade of ghrelin receptors may attenu-
ate the release of agouti related peptide (AgRP) and neuropeptide
Y (NPY) from the ARC, attenuate dopaminergic tone from the
VTA and noradrenergic tone from the brain stem to decrease
food intake all resulting in overall attenuated feeding responses
to chronic social stress. In our study, however, chronic blockade
of the ghrelin receptor in the PVN was not sufficient to attenuate
overall caloric intake.
In contrast, we did observe an increase in the intake of the
palatable diet in those animals that received [D-Lys-3]-GHRP-
6 into the PVN regardless of whether they were stressed or not.
This would suggest that ghrelin receptors in the PVN, while not
necessary for the overall feeding response seen during chronic
social defeat, may be necessary for the switch in dietary preference
that has been observed in stressed animals in previous studies
(Patterson et al., 2013). In these studies, mice with restricted
access to a high fat diet to 4 h during the day gradually increase
the proportion of calories consumed from this high fat diet while
decreasing the proportion of calories consumed from a regular
diet, indicating a bias toward the calorically dense and highly
palatable diet. When stressed, however, these mice increased the
intake of regular chow while decreasing the intake of the high fat
diet (Patterson et al., 2013). It is therefore, possible that stress
induced ghrelin secretion acts on the PVN to inhibit the intake
of high fat without altering total caloric intake. This would be
in accordance with data showing that the PVN is important for
dietary preference for carbohydrates and lesions to the PVN result
in increased preference for high fat diets (Aravich and Sclafani,
1983; Leibowitz, 1988; Hoebel et al., 1989). Interestingly, ghrelin
decreases inhibitory post synaptic currents in parvocellular neu-
rons within the PVN, primarily cells that secrete CRH (although
also in some TRH and other cells of unknown phenotype),
suggesting that ghrelin facilitates indirect activation of these
neuroendocrine cell groups (Cowley et al., 2003). Furthermore,
central ghrelin infusions increase extracellular norepinephrine
content in the PVN (Kawakami et al., 2008). Of course these
effects are acute and it is not known if they are the same in animals
subjected to chronic stress. Thus, while plasma ghrelin and CORT
levels correlate during acute stress, ghrelin secretion remains
elevated during chronic stress but the CORT response become
blunted (Zheng et al., 2009). Interestingly, our data shows that
chronic GHSR antagonism in the PVN results in higher plasma
CORT levels, an effect that seems more pronounced in stressed
animals (although not statistically significant). This would sug-
gest that ghrelin may be important in the adaptive mechanisms
that bring CORT levels down in the face of chronic stress. As such,
one would expect that chronic blockade of GHSR in the PVN
would make mice more vulnerable to stress induced pathological
conditions, a state previously shown in GHSR KO mice (Lutter
et al., 2008).
Finally, it is important to note that in our studies cannulae
placements were closer to the magnocellular portion of the PVN,
where cells that produce oxytocin, vasopressin, and galanin are
located (Akabayashi et al., 1994). All of these cell groups have been
associated with feeding, and ghrelin may influence the expression
of these peptides in the PVN directly or indirectly (Akabayashi
et al., 1994; Sclafani et al., 2007; Beck and Max, 2008). Thus, one
could argue that stress induced ghrelin secretion targets the PVN
to alter the preference of high fat diets via modulation of oxytocin,
vasopressin and galanin, a hypothesis that needs further study.
Possible limitations of this study are the use of [D-Lys-3]-
GHRP-6 to antagonize the ghrelin receptor. For instance, [D-Lys-
3]-GHRP-6 appears to interact with the 5-HT2b receptors in the
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gut (Depoortere et al., 2006) although this interaction needs to
be further demonstrated, as brain expression of this receptor is
low compared to the gut (Hayes and Greenshaw, 2011). Given
this finding, and the fact that other ghrelin receptor antagonists
appear to act centrally to cause weight gain in spite of blocking
the somatotropic effects of ghrelin (Halem et al., 2005), sup-
port the notion that the effects of [D-Lys-3]-GHRP-6, are related
to their interaction with the ghrelin receptor and not to other
receptors.
In summary, our results further demonstrate that chronic
social defeat stress results in increased caloric intake and pref-
erence for carbohydrate rich diets in mice. This preference for
carbohydrate (but not the overall increase in caloric intake) is
mediated by direct action of stress induced ghrelin secretion on
the PVN. Blockade of GHSR in the PVN biases animals toward
increasing their intake of high fat, whether they are stressed or
not. As such, the stress induced increases in caloric intake seen in
vehicle treated mice, and the increases in the intake of the high fat
diet are independent from each other and only the preference for
fat is related to blockade of ghrelin receptors in the PVN.
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